ResMed (RMD) reported that it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma. The addition of Propeller’s business is expected to have a dilutive impact on ResMed’s non-GAAP earnings per share in the range of $0.01 to $0.02 per quarter during the remainder of Fiscal Year 2019
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$41.25 |
Change
0.120(0.29%) |
Mkt cap ! $23.89B | |||
| Open | High | Low | Value | Volume |
| $41.47 | $41.47 | $41.23 | $34.47M | 834.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89 | $41.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $41.50 | 1500 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| RMD (ASX) Chart |